- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Sacubitril/Valsartan in Medicare Alternative Payment ModelsOptimizing utilization of sacubitril/valsartan for treatment of heart failure could improve provider performance in the Bundled Payments for Care Improvement initiative and the Medicare Shared Savings Program.
Latest:
AHA Telemetry Guidelines Improve Telemetry Utilization in the Inpatient SettingUsing Plan-Do-Study-Act cycles, the studied intervention reduced hospital inpatient telemetry time by 51.25% while increasing American Heart Association (AHA) guideline–based usage.
Latest:
Better Food, Better Health: Thinking Outside the BoxFor the conclusion to this 4-part video series, tune in to learn the lessons each organization will carry forward from this pilot program experience.
Latest:
Contributor: 3 Key Questions for the Biden Administration and the 117th Congress Coming Out of the COVID-19 CrisisThe incoming Biden administration will be challenged to address flex capacity, the supply chain, and real-time data as we transition from coronavirus disease 2019 (COVID-19) response to durable recovery.
Latest:
Safety Considerations and Practical Strategies for Using Bispecific Antibodies in Multiple MyelomaExplore the safety considerations and unique toxicities of bispecific antibodies, including cytokine release syndrome and neurotoxicity management.
Latest:
Predictors of Discharge From the VA Caregiver Support ProgramThe year of application predicts discharge from the Department of Veterans Affairs (VA) caregiver program. Unexpected, disallowed criteria also predict discharge, with significant others facing higher discharge risk than spouses.
Latest:
Medical Policy Determinations for Pharmacogenetic Tests Among US Health PlansThis analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.
Latest:
Inability to Access Health Care Due to COVID-19 Among Medicare BeneficiariesUp to one-fifth of Medicare beneficiaries were unable to access health care due to the COVID-19 pandemic in 2020.
Latest:
Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive SettingThe authors report overutilization of telemetry monitoring in a community setting, increasing the cost of health care and potential harm to patients with unnecessary interventions.
Latest:
Barriers and Facilitators to Managing Social Care in the Digital Era Among Michigan Health CentersThere is widespread interest in understanding the role of health care in meeting social needs. This study examines community-wide activities, resources, and information technology used to manage social care.
Latest:
Provider Perceptions of Pharmacists in Primary Care–Based Accountable Care OrganizationsIn this article, the authors describe their experiences addressing provider perceptions and methods to overcome several challenges to clinical pharmacist integration in primary care–based accountable care organizations.
Latest:
Navigating Adverse Events in Bispecific Antibody Therapies: Infection Prevention and ManagementRobert M. Rifkin, MD, FACP, discusses how the MagnetisMM-3 update at the 66th American Society of Hematology Annual Meeting and Exposition sheds light on elranatamab’s role in relapsed/refractory multiple myeloma while panelists discuss how emerging data on bispecific antibodies and combination strategies could shape treatment timing and improve outcomes, especially in heavily pretreated patients.
Latest:
Final Takeaways From the PanelistsPanelists discuss their final thoughts on the evolving landscape of alopecia areata (AA) treatment, summarizing key takeaways from the discussion and reflecting on future directions for patient care and therapy advancements.
Latest:
Contributor: Reframing Health Literacy—A Systemic Driver of Equity and OutcomesImproving health literacy is essential for promoting health equity, reducing preventable illness, and making health care more effective.
Latest:
Addressing the Opioid CrisisThe authors highlight the diversity of multiagency electronic data-sharing approaches and present a case study addressing the opioid crisis
Latest:
Overcoming Access, Cost Barriers in MS: Andrew Wolf, MDAndrew Wolf, MD, discusses the growing costs, treatment advances, and geographic disparities in multiple sclerosis care.
Latest:
Hospital Outcomes of Male Breast Cancer in the United StatesThis is the first study to estimate the hospital lengths of stay and costs of male breast cancer at the US population level.
Latest:
Contributor: Yearly Trends in Coverage Rates for GLP-1 RAs in Weight LossExplore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access challenges and payer coverage trends affecting treatment options.
Latest:
Final Thoughts on the Future of AML CarePanelists discuss how AML treatment has entered an exciting era of personalized medicine with increasing oral options and targeted therapies, while identifying immunotherapy as a major unmet need and expressing optimism about patients achieving long-term survival on current regimens.
Latest:
Service Line Care Delivery Model for COVID-19 Patient-Centric CareThe authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.
Latest:
Implementing Multistate Behavioral Health Pay-for-Performance Initiatives in Medicaid Managed CareThe authors describe a pay-for-performance initiative targeting behavioral health providers, which was introduced by a large Medicaid managed care organization across multiple states.
Latest:
Measuring Success and Real-World Outcomes for MASHPanelists discuss how defining and tracking meaningful real-world outcomes ensures accountability and value in MASH management.
Latest:
From MSSP ACOs to Employer Value: Translating Value-Based Principles to Self-Insured PlansValue-based care adoption in employer insurance requires replacing fragmented point solutions with unified, at-risk performance contracts that align vendors, providers, and members around total cost and quality goals.
Latest:
Baloxavir vs Oseltamivir: Reduced Utilization and Costs in InfluenzaBaloxavir, compared with oseltamivir, was associated with lower health care resource utilization and costs in patients with influenza, particularly those at high risk of secondary complications.
Latest:
Provider Barriers in Uptake of Biosimilars: Case Study on FilgrastimPrevious studies have found modest uptake of biosimilars in both commercial and Medicare populations. This study finds that the uptake varies between the rural and urban provider settings.
Latest:
Reducing Readmissions in the Safety Net Through AI and AutomationArtificial intelligence (AI) and electronic health record–based automation tools helped a safety-net health system meet performance-based readmission metrics, thereby retaining critical funding while improving clinical and equity outcomes.
Latest:
Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology PracticeReal-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.
Latest:
Addressing Virtual Care Disparities for Patients With Limited English ProficiencyWith increased use of virtual care due to the COVID-19 pandemic, the following recommendations address disparities for patients with limited English proficiency.
